Summary of Key Points Core Viewpoint - The company, Maide Medical (688310), has initiated a share buyback program, reflecting its strategy to enhance shareholder value and manage capital effectively [1]. Trading Information - On January 6, 2026, Maide Medical's stock closed at 15.9 yuan, experiencing a slight decline of 0.25% with a turnover rate of 1.91% and a trading volume of 31,800 shares, resulting in a total transaction value of 50.42 million yuan [1]. - The net outflow of main funds was 865,100 yuan, while speculative funds saw a net inflow of 1,532,600 yuan, and retail investors had a net outflow of 667,500 yuan on the same day [2]. Company Announcements - On January 5, 2026, Maide Medical conducted its first share buyback, acquiring 127,283 shares, which represents 0.0766% of the total share capital. The buyback price ranged from 15.69 yuan to 15.80 yuan per share, with a total expenditure of 2,004,504.07 yuan (excluding transaction fees) [1]. - This buyback is part of a plan approved by the shareholders on December 30, 2025, with funding sourced from either excess raised funds or the company's own funds. The buyback aims to reduce registered capital, with a planned duration of 12 months and a total buyback amount between 20 million yuan and 40 million yuan, while the maximum buyback price is set at 24 yuan per share [1].
股市必读:迈得医疗(688310)1月6日主力资金净流出86.51万元